There is evidence for the anti-proliferative effect of estrogen on lymphoid cells through estrogen receptor β (ERβ) signaling, inhibiting the proliferation of T cell lymphoma and Burkitt lymphoma cells in vitro [41]. This evidence concerns the gene ESR2 and T-cell non-Hodgkin lymphoma.